Results 41 to 50 of about 17,525 (227)

World Health Organization High Priority Pathogens: Ophthalmic Disease Findings and Vision Health Perspectives

Pathogens, 2021
Recent Ebola epidemics, the ongoing COVID-19 pandemic, and emerging infectious disease threats have highlighted the importance of global infectious diseases and responses to public health emergencies.
Sanjana Kuthyar, Casey L. Anthony, Tolulope Fashina, Steven Yeh, Jessica G. Shantha   +4 more
doaj   +1 more source

Proportion of Deaths and Clinical Features in Bundibugyo Ebola Virus Infection, Uganda

Emerging Infectious Diseases, 2010
The first known Ebola hemorrhagic fever (EHF) outbreak caused by Bundibugyo Ebola virus occurred in Bundibugyo District, Uganda, in 2007. Fifty-six cases of EHF were laboratory confirmed.
Adam MacNeil, Eileen C. Farnon, Joseph F. Wamala, Sam Okware, Deborah L. Cannon, Zachary Reed, Jonathan S. Towner, Jordan W. Tappero, Julius Lutwama, Robert Downing, Stuart T. Nichol, Thomas G. Ksiazek, Pierre E. Rollin   +12 more
doaj   +1 more source

Ebola Virus Infection [PDF]

Mediterranean Journal of Infection, Microbes and Antimicrobials, 2014
Ebola virus is one of the cause of viral hemorrhagic fever with high mortality rate. This recent West African outbreak is the largest Ebola outbreak in history. The current Ebola outbreak is caused by Zaire Ebola virus species. Ebola virus disease can be
İlkay BOZKURT, Hakan LEBLEBİCİOĞLU
doaj   +1 more source

Ebola Haemorrhagic Fever in Africa: a Necessary Highlight [PDF]

, 2019
The purpose of this commentary is to re-evaluate the historic and scientific facts on Ebola haemorrhagic fever and the role of the International community, especially Economic Community of West African States (ECOWAS) in stemming the tide.
Adu-Gyamfi, S. (Samuel)
core   +3 more sources

An experience in the clinical use of specific immunoglobulin from horse blood serum for prophylaxis of Ebola haemorrhagic fever

Вопросы вирусологии, 2017
The aim of this work was to estimate the efficacy and safety of single intramuscular introduction of specific heterologous immunoglobulin as prophylactic drug against Ebola hemorrhagic fever. Materials and methods.
I. V. Borisevich, N. K. Chernikova, V. I. Markov, V. P. Krasnianskiy, S. V. Borisevich, E. V. Rozhdestvenskiy   +5 more
doaj   +1 more source

Resurgence of Ebola in Uganda: Response Strategies, Lessons Learned, and Future Directions. [PDF]

Health Sci Rep
ABSTRACT Introduction The recent resurgence of Ebola virus disease (EVD), specifically the Sudan virus strain, in Uganda highlights the ongoing threat of emerging infectious diseases. This article aims to analyze the multifaceted factors contributing to this resurgence, evaluate the public health impact, and assess the effectiveness of response ...
Edward M, Muhigi S, Mundua J, Ally A.
europepmc   +2 more sources

Viewpoint: filovirus haemorrhagic fever outbreaks: much ado about nothing? [PDF]

, 2000
The recent outbreak of Marburg haemorrhagic fever in the Democratic Republic of Congo has put the filovirus threat back on the international health agenda.
Boelaert, M, Borchert, M, Colebunders, R, Muyembe-Tamfum, J J, Pirard, P, Sleurs, H, van der Groen, G, Van der Stuyft, P   +7 more
core   +3 more sources

Reemerging Sudan Ebola Virus Disease in Uganda, 2011

Emerging Infectious Diseases, 2012
Two large outbreaks of Ebola hemorrhagic fever occurred in Uganda in 2000 and 2007. In May 2011, we identified a single case of Sudan Ebola virus disease in Luwero District.
Trevor Shoemaker, Adam MacNeil, Stephen Balinandi, Shelley Campbell, Joseph Francis Wamala, Laura K. McMullan, Robert Downing, Julius Lutwama, Edward Mbidde, Ute Ströher, Pierre E. Rollin, Stuart T. Nichol   +11 more
doaj   +1 more source

Elevated l-threonine is a biomarker for Lassa fever and Ebola

Virology Journal, 2020
Background Lassa fever and Ebola are characterized by non-specific initial presentations that can progress to severe multisystem illnesses with high fatality rates.
Trevor V. Gale, John S. Schieffelin, Luis M. Branco, Robert F. Garry, Donald S. Grant   +4 more
doaj   +1 more source

Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time

Nature Communications, 2020
Outbreaks of viral hemorrhagic fevers highlight the need for sensitive, field-deployable diagnostics. Here the authors present a CRISPR-based SHERLOCK platform with field protocol and mobile app for Ebola and Lassa fever outbreaks.
Kayla G. Barnes, Anna E. Lachenauer, Adam Nitido, Sameed Siddiqui, Robin Gross, Brett Beitzel, Katherine J. Siddle, Catherine A. Freije, Bonnie Dighero-Kemp, Samar B. Mehta, Amber Carter, Jessica Uwanibe, Fehintola Ajogbasile, Testimony Olumade, Ikponmwosa Odia, John Demby Sandi, Mambu Momoh, Hayden C. Metsky, Chloe K. Boehm, Aaron E. Lin, Molly Kemball, Daniel J. Park, Luis Branco, Matt Boisen, Brian Sullivan, Mihret F. Amare, Abdulwasiu B. Tiamiyu, Zahra F. Parker, Michael Iroezindu, Donald S. Grant, Kayvon Modjarrad, Cameron Myhrvold, Robert F. Garry, Gustavo Palacios, Lisa E. Hensley, Stephen F. Schaffner, Christian T. Happi, Andres Colubri, Pardis C. Sabeti   +38 more
doaj   +1 more source